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Background: Converging evidence indicates that neural 
oscillations coordinate activity across brain areas, a process 
which is seemingly perturbed in schizophrenia. In particu-
lar, beta (13-30 Hz) and gamma (30–50 Hz) oscillations 
were repeatedly found to be disturbed in schizophrenia and 
linked to clinical symptoms. However, it remains unknown 
whether abnormalities in current source density (CSD) and 
lagged phase synchronization of oscillations across distrib-
uted regions of the brain already occur in patients with an 
at-risk mental state (ARMS) for psychosis. Methods: To 
further elucidate this issue, we assessed resting-state EEG 
data of 63 ARMS patients and 29 healthy controls (HC). 
Twenty-three ARMS patients later made a transition to 
psychosis (ARMS-T) and 40 did not (ARMS-NT). CSD 
and lagged phase synchronization of neural oscillations 
across brain areas were assessed using eLORETA and 
their relationships to neurocognitive deficits and clinical 
symptoms were analyzed using linear mixed-effects models. 
Results: ARMS-T patients showed higher gamma activity 
in the medial prefrontal cortex compared to HC, which was 
associated with abstract reasoning abilities in ARMS-T. 
Furthermore, in ARMS-T patients lagged phase synchro-
nization of beta oscillations decreased more over Euclidian 
distance compared to ARMS-NT and HC. Finally, this 
steep spatial decrease of phase synchronicity was most pro-
nounced in ARMS-T patients with high positive and nega-
tive symptoms scores. Conclusions: These results indicate 
that patients who will later make the transition to psychosis 
are characterized by impairments in localized and synchro-
nized neural oscillations providing new insights into the 
pathophysiological mechanisms of schizophrenic psychoses 
and may be used to improve the prediction of psychosis.
Key words:  schizophrenia/at-risk mental state 
(ARMS)/resting state/EEG
Introduction
Converging evidence suggests that an impaired dynamic 
coordination of activity across distributed brain areas 
underlies the cognitive and behavioral abnormalities that 
characterize psychosis.1–4 Neural oscillations coordinate 
distributed activity through phase synchronization,5 and 
patients with schizophrenia display altered neural oscil-
lations, particularly in the beta (13–30 Hz) and gamma 
(30–50 Hz) frequency bands.3,6 Together, these findings 
suggest that alterations in higher frequency oscillations 
and their phase synchronization may disrupt coordinated 
activity across distributed cortical areas, thereby leading 
to the formation of psychotic symptoms and cognitive 
impairments.
Gamma oscillations are strongly associated with the 
integration of cognitive information7–9 and have been 
shown to be consistently perturbed in patients with 
schizophrenia.3,10,11 Interestingly, both an elevated and 
reduced gamma activity has been reported in patients with 
schizophrenia.12 However, an increase has consistently 
been found in unmedicated patients experiencing positive 
symptoms (such as hallucinations and delusions), while 
the reverse is apparent in those suffering from negative 
symptoms (such as social withdrawal, lack of motiva-
tion, and flat affect).11,12 Although both gamma and beta 
oscillations synchronize with enhanced precision over 
small distances, the beta oscillations have been shown to 
be particularly important in modulating long-range syn-
chronization,13,14 which is the interaction among widely 
distributed neocortical regions. For instance, the phase 
synchronization of beta oscillations between extra-striate 
areas15 and between temporo-parietal areas16 have been 
shown to mediate attentional processes. Interestingly, 
all these processes are deeply perturbed in patients with 
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schizophrenia,17–19 further suggesting a disturbed long-
ranged neural communication. As a coordinator of these 
large-network interactions, the beta frequency is there-
fore a prime candidate to be studied.
Although several EEG studies have been conducted on 
first episode psychosis (FEP) and chronic schizophrenia 
patients, studies on prodromal patients are scarce. This 
is unfortunate because schizophrenia is now increasingly 
seen as a neurodevelopmental disorder20 and thus study-
ing neurophysiological abnormalities in at-risk mental 
state (ARMS) patients would offer a unique opportunity 
to unravel the etiopathology of the disease.19 Furthermore, 
previous studies on ARMS patients21,22–24 did not make 
use of electrophysiological neuroimaging methods such 
as eLORETA which allows a reliable source localization 
of brain activity along with various connectivity analyses 
of frequencies.25 Moreover, studies were frequently based 
on patients treated with antipsychotic drugs, which could 
have severely obfuscated the discovery of neurophysi-
ological correlates of psychopathology.26
Thus, we compared beta and gamma oscillations in 3 
relatively large and antipsychotic-naive groups, ie, ARMS 
patients with later transition to psychosis (ARMS-T), 
ARMS patients without later transition to psychosis 
(ARMS-NT) and healthy controls (HC). We not only 
assessed the current source density (CSD) at these fre-
quency bands, but also their lagged phase synchroni-
zation across brain areas as a function of Euclidian 
distance. We hypothesized that ARMS-T patients would 
demonstrate abnormal CSD in both the high gamma and 
beta frequency bands when compared with ARMS-NT 
and HC. Furthermore, we postulated that the lagged 
phase synchronization of beta, the long-range modula-
tor, would be more decreased in ARMS-T compared to 
ARMS-NT and HC as a function of increasing Euclidian 
distance.
Methods
Setting and Recruitment
The EEG data analyzed in this study were collected as 
part of the Basel Früherkennung von Psychosen (FePsy) 
project, a prospective multilevel study, which aims to 
improve the early detection of psychosis.27 The study was 
approved by the ethics committee of the University of 
Basel, and all participants provided written informed con-
sent. Patients recruited for this study were help-seeking 
consecutive referrals to the FePsy Clinic at the University 
Psychiatric Clinics Basel, which was specifically set up to 
identify, assess, and treat individuals in the early stages 
of psychosis.
Screening Procedure
We used the Basel Screening Instrument for Psychosis 
(BSIP)28 to identify ARMS individuals. The BSIP is 
based on the PACE inclusion/exclusion criteria29 and 
has been shown to have a high predictive validity and a 
good interrater reliability.28 Exclusion criteria for patients 
were age younger than 18  years, insufficient knowledge 
of German, IQ < 70, previous episode of schizophrenic 
psychosis (treated with major tranquilizers for >3 weeks 
[lifetime] and 125 mg chlorpromazine equivalent/day), 
psychosis clearly due to organic reasons or substance 
abuse, or psychotic symptoms within a clearly diag-
nosed depression or borderline personality disorder. 
For this study, we included all ARMS patients that were 
recruited for the FePsy study between March 2000 and 
August 2013 and had a clinical EEG session of at least 
15 min at baseline assessment. They were followed-up at 
regular intervals in order to distinguish those who later 
transitioned to frank psychosis (ARMS-T) from those 
who did not (ARMS-NT). During the first year of the 
follow-up, ARMS individuals were assessed for transi-
tion to psychosis monthly, during the second and third 
years 3-monthly, and thereafter annually using the tran-
sition criteria of Yung et  al.29 In this study, individuals 
were only classified as ARMS-NT if  they had a follow-up 
duration of at least 3  years and did not develop frank 
psychosis. HC were recruited from trade schools, hospital 
staff, and through advertisements. Inclusion criteria for 
the healthy participants were: no history of psychiatric or 
neurological disease, no past or present substance abuse 
or head trauma.
EEG Recordings and Data Acquisition
EEG data were recorded at the University Hospital of 
Basel. Patients sat in a quiet room during eyes closed 
resting-state condition for about 20 min. Every 3 min, 
subjects were asked to open their eyes for a period of 5–6 
s.  At any signs of behavioral and/or EEG drowsiness, 
the patients were verbally asked to open their eyes. EEG 
data were sampled at a rate of 250 Hz by 19 gold cup 
electrodes (Nicolet Biomedical, Inc.) referenced to linked 
ears. Electrodes impedances were kept below 5Ω.
Artifact Rejection
EEG pre-processing was performed using Brain Vision 
Analyzer 2.0 software (Brain Products GmbH). We pro-
cessed each EEG in parallel split into 2 branches, one fil-
tered at 0.5 Hz and one at 1 Hz. We did so in order to apply 
the ICA matrix from the most stable signal (1 Hz) to the 
one that conserved the most signal (0.5 Hz). Both branches 
were handled in the same way up to the step that involved re-
referencing to the common average. As a first step, artifact 
rejection was performed manually, based on visual inspec-
tion, to remove epochs containing extreme ocular artifacts, 
muscles and/or cardiac contamination and bad signals due 
to random movements. Biased extended Infomax ICA 
analyses were then performed for the removal of residual 
eye movements, eye-blinking, muscles and non-biological 
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components contaminated with high gamma frequencies 
of 50 Hz and above as measured by Fast Fourier Transform 
(FFT) of the ICA components (resolution at 1 Hz, power 
μV2, hanning window length of 10%). After applying the 
ICA corrected matrix of the data filtered at 1 Hz to the one 
filtered at 0.5 Hz, we re-referenced the data to common 
average. Finally, another manual rejection based on visual 
inspection was performed to exclude remaining artifacts as 
mentioned above.
EEG Current Source Localization Density Analysis
To compute the cortical CSD of neural oscillations, we 
used exact low-resolution electromagnetic tomography 
(eLORETA)25 on EEG data segmented into 2s epochs 
(on average 669 segments per subject). Patient groups did 
not significantly differ in number of segments. eLORETA 
is a neurophysiological imaging technique based on a 
weighted minimum norm inverse solution procedure 
allowing for the 3D modeling of the EEG CSD with 
an exact localization performance, but with a high cor-
relation of neural sources that are in close proximity. 
Numerous studies based on neuroimaging tools, such as 
functional30,31 and structural magnetic resonance imag-
ery (MRI),32 positron emission tomography (PET),33–35 
and intracranial EEG recordings,36,37 have validated 
LORETA as an efficient and reliable tool to study brain 
activity. Compared with the first version of LORETA,38 
eLORETA has no localization bias in the presence of 
structured noise in simulated data.39
In eLORETA, a 3-shell spherical head model (brain, 
scalp, and skull compartments) is used and the solution 
space is restricted to the cortical gray matter/hippocampus, 
which comprises 6239 voxels of 5 mm × 5 mm × 5 mm each. 
The head model for computing the lead field is based on the 
Montreal Neurological Institute (MNI) brain MRI average.40
Lagged Phase Synchronization Analysis
For a spatially unbiased lagged phase synchronization 
analysis we defined regions of interests (ROIs) based on 
the MNI coordinates of the cortical voxel underlying 
the 19 electrode sites41 (for technical details, see supple-
mentary appendix 3). We used a single voxel for each 
ROI because eLORETA’s spatial resolution is relatively 
low, and expanding the ROI to neighboring voxels could 
potentially bias the analysis due to the high correlation 
among them.41 Next, we computed the lagged phase syn-
chronization between all 19 ROIs resulting in a relatively 
high number (ie, 171)  of pairwise combinations. Lagged 
phase synchronization quantifies the non-linear relation-
ship between 2 ROIs after the instantaneous zero-lag con-
tribution has been removed. Removing this instantaneous 
zero-lag contribution has been shown to eliminate non-
physiological artifacts, such as volume conduction, which 
biases relationship measurements such as instantaneous 
connectivity.25 Finally, we used the statistical software 
R42 for calculating the distances between ROIs in 3D in 
order to asses local vs global phase synchronization. The 
Euclidian distance between ROI1 (x1, y1, z1) and ROI2 (x2, 
y2, z2) were calculated using the Pythagorean theorem: 
√[(x2−x1)
2 + (y2−y1)
2 + (z2−z1)
2] and were subsequently 
standardized into z-scores.
Neurocognitive Assessment
In order to assess the participants’ non-verbal capabilities 
to process and integrate higher-order relationships between 
individual entities we used the Leistungsprüfsystem Scale 
3 (LPS-3), a well-established German intelligence scale 
for assessing nonverbal (abstract reasoning) abilities.43 To 
assess working memory, we used the 2-back task of the 
Testbatterie zur Aufmerksamkeitsprüfung (TAP).44
Assessment of Positive and Negative Psychotic 
Symptoms
The Brief  Psychiatric Rating Scale Expanded (BPRS-E)45,46 
was used to assess positive and negative psychotic symp-
toms. The positive psychotic symptom scale was based 
on the 4 items hallucinations, suspiciousness, unusual 
thought content, and conceptual disorganization and the 
negative psychotic symptom scale was based on the items 
blunted affect, psychomotor retardation and emotional 
withdrawal, as defined by Velligan et al.47
Statistical Analyses
In order to identify the CSD differences between groups 
(ARMS-NT vs HC, ARMS-T vs HC, ARMS-NT vs 
ARMS-T), we used statistical nonparametric mapping 
(SnPM).48 The use of SnPM in eLORETA has been 
validated49,50 and utilized in previous clinical studies.41,51 
Differences in cortical oscillations between groups in each 
frequency band were assessed by voxel-by-voxel independent 
sample F-ratio-tests with a frequency wise normalization. To 
correct for multiple comparisons across all voxels and all fre-
quencies, a total of 5000 permutations were used to calculate 
the critical probability threshold (5% probability level).
Next, CSD values were extracted at those ROI that dif-
fered between groups and their association with LPS-3 
and 2-back tasks performance scores was assessed by 
linear regression models using neuropsychological per-
formance scores as dependent variables and CSD values, 
diagnostic group, age, and years of education as indepen-
dent variables. To test whether the associations between 
CSD values and neuropsychological performance dif-
fered between groups, an interaction term between group 
and CSD values was included. In addition to this ROI 
approach, a whole brain analysis was performed by cor-
relating voxel-wise these performance measures with 
CSD. Furthermore, to correct for multiple testing, this 
whole brain analysis was based on 5000 permutations to 
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determine the empirical probability distribution for the 
maximal statistics under the null hypothesis.41,52
To assess group differences in lagged phase synchroni-
zation, we fitted a linear mixed-effects model using lagged 
phase synchronization of the ROI pairs (171 pairs) as the 
dependent variable and Euclidian distance (within-subjects) 
and group (between-subjects) along with their interaction as 
independent variables. The model also included an intercept 
term that randomly varied per individual. To investigate the 
impact of positive and negative symptoms on the lagged 
phase synchronization as a function of anatomical distances, 
we applied linear mixed-effects models that additionally 
included BPRS positive and negative symptoms as indepen-
dent variables. Furthermore, these analyses were repeated for 
each of the seven different frequencies and corrected for mul-
tiple comparison using the Benjamini–Hochberg method.53
Results
Sample Description
Until August 2013, 134 ARMS patients and 97 HC 
were recruited for the FePsy study. Of these, 63 ARMS 
and 29 HC had sufficient EEG and follow-up data to 
be included in the present study. Twenty-three of  the 
included ARMS patients had made a transition to psy-
chosis (ARMS-T) during the follow up and 40 had not 
(ARMS-NT). None of  those who made a transition con-
verted to psychotic mood disorder. The 71 ARMS indi-
viduals that were excluded from this study did not differ 
from the included ARMS individuals with regard to gen-
der, sex, years of  education, and BPRS total and positive 
symptoms scores. Demographic and clinical characteris-
tics of  the 3 groups (ie, HC, ARMS-T, and ARMS-NT) 
are shown in table  1. There was a small overall differ-
ence in age (P = .046), which was due to a lower age in 
HC compared to ARMS-NT, significant at a trend level 
(P = .053). Furthermore, ARMS-T patients had higher 
positive symptoms than ARMS-NT (P = .005). Almost 
all ARMS individuals were antipsychotic naïve; only 
4 ARMS individuals (4/63) had received low doses of 
second-generation antipsychotic medication during no 
more than 3 weeks for behavioral control by the refer-
ring psychiatrist or general practitioner prior to study 
inclusion.
Table 1.  Demographic and Clinical Characteristics of HC, ARMS-T, and ARMS-NT Individuals
HC ARMS-NT ARMS-T P Value
N = 29 N = 40 N = 23
Gender .597
 Women 14 (48.3%) 15 (37.5%) 11 (47.8%)
 Men 15 (51.7%) 25 (62.5%) 12 (52.2%)
Age 22.4 (5.02) 26.5 (8.42) 26.3 (7.13) .046
Years of education 11.9 (1.93) 11.6 (3.49) 11.2 (2.41) .693
Antidepressants currently 1.000
 No 30 (75.0%) 17 (73.9%)
 Yes 10 (25.0%) 6 (26.1%)
Antipsychotics currently .619
 No 38 (95.0%) 21 (91.3%)
 Yes 2 (5.00%) 2 (8.70%)
Mood stabilizer currently .365
 No 40 (100%) 22 (95.7%)
 Yes 0 (0.00%) 1 (4.35%)
Tranquilizer currently .713
 No 35 (87.5%) 19 (82.6%)
 Yes 5 (12.5%) 4 (17.4%)
BPRS positive symptoms 6.33 (2.39) 8.67 (2.71) .001
BPRS negative symptoms 5.60 (2.72) 5.40 (2.74) .795
BPRS total score 37.7 (10.5) 42.1 (9.89) .137
Risk group .116
 Prepsychotic only (APS or BLIPS) 25 (62.5%) 18 (78.3%)
 Genetic risk only 3 (7.50%) 0 (0.00%)
 Mixed prepsychotic + genetic 6 (15.0%) 5 (21.7%)
 Unspecific only 6 (15.0%) 0 (0.00%)
LPS (nonverbal IQ) 119 (9.31) 115 (10.6) 112 (14.3) .204
2-back task correct responses 13.5 (1.46) 12.0 (3.24) 11.2 (2.51) .044
Days between EEG and transition to psychosis 423 (449)
Note: HC, healthy controls; ARMS-NT, at-risk mental state patients without later transition to psychosis; ARMS-T, at-risk mental state 
patients with later transition to psychosis; BPRS, Brief  Psychiatric Rating Scale; LPS, Leistungsprüfsystem; APS, attenuated psychotic 
symptoms; BLIPS, brief, limited intermittent psychotic symptoms. Categorical and continuous variables were compared by Pearson χ2 
(or Fisher’s exact tests if  any expected cell frequencies were <5) and ANOVAs, respectively.
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Source Localization
The average CSD in ARMS-T, ARMS-NT, and HC at 
each frequency band are depicted in figure 1. In ARMS-T 
and ARMS-NT, the highest CSD values were present in 
the delta (0.82 vs 0.63 µA/mm2) followed by the gamma 
frequency band (0.67 vs 0.57 µA/mm2), whereas in HC 
they were in alpha2 (0.55 µA/mm2) and delta (0.43 µA/
mm2), respectively. In ARMS-T patients delta activity 
seemed to be relatively distributed throughout the cortex, 
particularly in frontal and parieto-occipital areas, while 
in HC and ARMS-NT delta activity was more localized 
in the frontal cortex. In the gamma band, source fron-
tal activity seemed to progressively increase from HC to 
ARMS-NT to ARMS-T. Interestingly, statistical analy-
ses confirmed that ARMS-T had increased gamma activ-
ity in the medial prefrontal cortex (mPFC) bilaterally 
(BA 10), with a global maximum in the left hemisphere 
(X = −5, Y = 66, Z = 15, t = 4.59, P <  .05, corrected) 
(see figure 2a).
Current Source Analyses and Neurocognitive 
Measurements
A linear regression model with cognitive performance 
in the LPS-3 as dependent variables and CSD activity 
in the gamma frequency band at the mPFC and group 
(ARMS-T vs HC) as independent variables revealed 
a significant main effect of group (P < .001, corrected) 
and interaction between group and mPFC activity (P < 
.001, corrected). This interaction was due to a positive 
relationship between LPS-3 and mPFC activity in the 
ARMS-T group (P < .001, corrected) but not in HC 
(P = .140, corrected) (see figure 2b). In a similar model 
including performance in the 2-back task as dependent 
variable, there were no significant main effect of mPFC 
activity and interaction effect between mPFC activity and 
group when corrected for multiple comparisons. These 
results were also found using conventional EEG mea-
surements (supplementary appendix 1). A  whole brain 
voxel-wise correlation analysis revealed that the CSD 
of gamma oscillations was highly correlated with LPS-3 
performance in ARMS-T (r = .734, P < .001, corrected), 
but not in ARMS-NT and HC, and the global maximum 
was located at (X = −5, Y = 65, Z = 15) (supplementary 
appendix 2).
Lagged Phase Synchronization Across Distributed 
Brain Regions
Linear mixed-effects models with lagged phase syn-
chronization as dependent variables, Euclidian distance, 
group and their interaction as independent variable and 
a random intercept per subject, revealed significant main 
effects of Euclidian distance for each frequency band (all 
Ps < .001, corrected). This was due to decreased lagged 
phase synchronization with increasing distances between 
the ROIs (171 pairs) in all frequencies except for the delta 
band, which demonstrated an opposite association. In 
addition, there was a significant interaction between group 
and Euclidian distance for lagged phase synchronization 
Fig. 1. For illustrative purposes, the average current source density (µA/mm2) by group and frequency bands.
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of beta1 oscillations (P < .001, corrected), which was 
due to a stronger decrease of lagged phase synchroniza-
tion with increasing anatomical distance in the ARMS-T 
group compared to the ARMS-NT and HC groups (see 
figure 3).
Moreover, a linear mixed-effect model that addition-
ally included BPRS positive symptoms as an independent 
variable revealed a significant second order interaction 
between lagged phase synchronization, distance and 
BPRS positive symptoms in the beta1 frequency band 
(P  =  .002, corrected), indicating that higher positive 
symptoms in the ARMS-T group was associated with a 
particular strong decrease of lagged phase synchroniza-
tion with increasing distance (see figure  4a). The same 
interaction occurred with negative symptoms (P = .022, 
corrected) (see figure 4b). In both models, the interaction 
between Euclidian distance and group remained signifi-
cant, indicating that this interaction was not due to dif-
ferent psychopathology in ARMS-T and ARMS-NT.
Discussion
In this study, we assessed by means of electrophysiological 
neuroimaging methods the CSD distribution and lagged-
phase synchronization of neural oscillations across brain 
areas in patients at-risk for psychosis and HC. Consistent 
with our predictions, we found: (1) in comparison to HC, 
increased CSD of frontal gamma oscillations (30–50 Hz) 
in those patients who later transitioned to psychosis. 
Moreover, in ARMS-T gamma activity was positively 
Fig. 2. (A) eLORETA statistical map of gamma band differences between ARMS-T and HC and (B) correlations between gamma activity 
(µA/mm2) at the medial prefrontal cortex (mPFC) and LPS-3 performance in ARMS-T and HC.
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correlated with cognitive performance as assessed by 
the LPS-3. (2) We revealed that the inverse relationship 
between lagged phase synchronization and Euclidian dis-
tance was steeper in the ARMS-T patients than the other 
groups. This effect was most pronounced in patients with 
elevated negative and positive symptoms. These findings 
provide strong evidence that patients who will later make 
the transition to psychosis are characterized by impair-
ments in neural oscillations.
CSD Analyses
The revealed alteration in mPFC gamma oscillations in 
ARMS-T patients is in line with numerous studies report-
ing abnormal gamma oscillations in  schizophrenia2,54,55 
and extends these findings by demonstrating that prefron-
tal gamma oscillations are already affected in high-risk 
patients that later transitioned to psychosis. Although 
both an increase and a decrease of gamma oscillations 
have extensively been documented in patients suffering 
from psychosis, an increase has mostly been found in 
unmedicated patients exhibiting positive symptoms.11 
This is in line with our ARMS-T patients who fit these 
criteria and could explain the here revealed increase in 
the medial prefrontal gamma oscillations.
As the mPFC has been shown to be modulated by 
gamma oscillations56 and to be associated with seem-
ingly disparate cognitive functions such as detecting 
high-order relationships,57–60 planning and visualizing 
the future61 and constructing social and emotional judg-
ments,62 our finding of increased gamma activity sug-
gests that ARMS-T patients, already at baseline, have an 
impaired mPFC that could potentially explain cognitive 
abnormalities.63,64 Indeed, we found that gamma oscilla-
tion in mPFC [Brodmann area (BA) 10] correlated with 
neurocognitive performance in the LPS-3, a task in which 
patients are asked to find which item does not belong to a 
series of shapes. Such a detection of a higher-order rela-
tionship between individual entities was previously found 
to be associated with activation in BA 10 in semantic57,59 
Fig. 3. The lagged phase-synchronization of the beta 1 frequency band as a function of distance. Shaded areas cover regression 
coefficients with ±1 SE.
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and visual-based tasks,58,60 which is in line with the here 
revealed association between LPS-3 performance and 
mPFC gamma oscillations. However, the correlation 
between LPS-3 performance and gamma oscillations 
was positive, suggesting that increased medial prefron-
tal gamma oscillations in the ARMS-T group may be 
an adaptive and compensatory process. A  speculative 
explanation would be that patients with a high capacity 
to detect higher-order relationships, as indexed by the 
LPS-3 test and by gamma oscillation in the BA10, are 
more cognitively equipped to make sense of their altered 
psychological state.
Lagged Phase Synchronization Across Distributed 
Brain Regions
We revealed that ARMS-T patients show stronger decreas-
ing lagged phase synchronicity with increasing Euclidian 
distance than ARMS-NT and HC (figure 3). This nega-
tive association is particularly present in patients with 
high positive symptoms (figure 4).
Thus, through the increased synchronization in the 
shorter inter-regional distances of the brain character-
ized in ARMS-T individuals, the influence of the long-
range synchronicity is reduced. This could result from the 
disruption in the volume and organization of anatomical 
Fig. 4. (A) The lagged phase-synchronization of the beta 1 frequency band as a function of distance for each of 4 different values of 
BPRS positive symptoms. (B) The lagged phase-synchronization of the beta 1 frequency band as a function of distance for each of 4 
different values of BPRS negative symptoms. Shaded areas cover regression coefficients with ±1 SE.
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connections, which is supported by the findings of reduced 
grey matter volume in ARMS-T65 and its association with 
beta oscillations.3 Therefore, this could lead to the situ-
ation that distributed cortical areas can no longer com-
municate efficiently and that psychological entities like 
perception and cognition are no longer adequately inte-
grated. These findings support the increasingly accepted 
notion that the neuropsychological impairments associ-
ated with schizophrenic psychoses are due to distributed 
impairments involving the coordinated activity among 
numerous cortical areas.3 Importantly, given that we 
observed increased synchronization in the beta1 band 
already before transition to psychosis, this could indicate 
an increased liability for psychosis and thereby help to 
improve the prediction of psychosis.
Limitations
The results of the present study are constrained by a num-
ber of limitations: All data were acquired using a relatively 
low-density EEG system which is commonly used in the 
clinical field for practical reasons. Even though numer-
ous recent studies have shown that CSD and connectivity 
analyses during resting-state could reliably be performed 
using a 19 channels EEG system,66–68 we believe that the 
true potential of the eLORETA analyses could not be 
fully utilized. Moreover, to control for the strong correla-
tion between adjacent voxels in the phase synchronization 
analyses, we could only choose 19 ROIs that would be 
measured by 19 channels and yield only 171 connections. 
Therefore, future studies should conduct these analyses 
again using higher density EEG systems.
Conclusion
Taken together, our result of a heightened gamma activ-
ity in the mPFC in ARMS-T patients could potentially 
reveal the neural underpinnings for an abnormal cogni-
tive integration. Moreover, the increased lagged phase 
synchronicity characterized across smaller inter-regional 
brain areas in the beta1 frequency suggests anatomical 
abnormalities that could be hindering the proper commu-
nication between various cortical areas. These findings 
provide strong evidence that patients who will later make 
the transition to psychosis are characterized by impair-
ments in neural oscillations.
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